[Clinico-experimental evaluation on the use of sulprostone, new PGE2 derivative. I. Interruption of pregnancy in the first trimester].
D000020:Abortifacient Agents, Nonsteroidal; D000293:Adolescent; D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*
D000020:Abortifacient Agents, Nonsteroidal; D011459:Prostaglandins E, Synthetic; C016767:sulprostone; D015232:Dinoprostone
Valutazioni clinico-sperimentali sull'uso del sulprostone, nuovo derivato PGE2. Nota I. Interruzione di gravidanza al primo trimestre.